I. Introduction
Glaucoma is the leading cause of irreversible blindness worldwide. It is estimated that the number of patients will be 111.8 million in 2040, with affected older people mainly in Asia and Africa [1]. Glaucoma causes progressive retinal nerve fiber layer (RNFL) loss, which leads to visual field abnormalities and blindness in untreated patients. However, people often do not seek an ophthalmic examination because the disease is mostly asymptomatic until in an advanced stage. The number of undiagnosed cases was 90% in Brazil, 85.1% in Singapore and 55% – 78% in the US [2]–[6]. Early detection of glaucoma is important for the prevention of blindness. However, the conventional methods are not suitable for screening.